March 13, 2021
Factors to Consider in the Initial Treatment Approach
Factors to Consider in the Initial Treatment Approach
This webinar will provide an overview of MDS and what treatment path to take in a patient newly diagnosed with myelodysplastic syndromes. Factors, such as: the type of MDS; the prognostic score (risk score) of the MDS; a person’s age, overall health, and preferences will be discussed.
Speaker
YM
Yazan F. Madanat, MD
Our Supporters
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, Acceleron, and Gamida Cell for supporting this initiative.
